At recent prices, you can buy shares of Merck (NYSE: MRK) that offer a yield above 3%, and shares of Pfizer (NYSE: PFE) offer ...
NEW YORK & TOKYO - Pfizer Inc. (NYSE: NYSE:PFE) and Astellas Pharma Inc. (TSE: TYO:4503) have announced updated results from the Phase 3 EV-302 clinical trial, which showed that the combination of ...
Global pharmaceutical company Pfizer (NYSE:PFE) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 21.9% year on year to $17.76 billion. On the other hand, the company ...
Pfizer (PFE) is set to announce Q4 earnings, with analysts expecting a $0.46 profit per share and $17.26B revenue.
5d
Investing News Network on MSNAmgen, Merck and Pfizer Release Latest Quarterly Earnings, Share 2025 PlansEarnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February 4 ...
Pfizer Inc. (NYSE:PFE – Get Free Report) shares traded up 2.9% on Wednesday following a stronger than expected earnings report. The company traded as high as $26.69 and last traded at $26.62.
Pfizer (NYSE:PFE – Get Free Report) had its price objective decreased by equities research analysts at Citigroup from $30.00 ...
Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...
We recently compiled a list of the 12 Best 5% Dividend Stocks To Buy According To Hedge Funds. In this article, we are going ...
Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...
We can see that Pfizer Inc. (NYSE:PFE) does use debt in its business. But the real question is whether this debt is making the company risky. Debt is a tool to help businesses grow, but if a business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results